Atossa Therapeutics Inc (NASDAQ:ATOS)

3.63
Delayed Data
As of Jul 08
 +0.15 / +4.29%
Today’s Change
0.76
Today|||52-Week Range
4.27
+131.21%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +10.19% increase from the last price of 3.63.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$0.00
Reporting Date
Aug 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.50%
 
 
 
 
 
 
Growthannually 36.95%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.